Evidence map›Paper›PMID 27058889›Full record

ArticleOncotarget2016

The angiogenesis in decellularized scaffold-mediated the renal regeneration.

Jin Mei, Yaling Yu, Miaozhong Li, Shanshan Xi, Sixiao Zhang, Xiaolin Liu, Junqun Jiang, Zhibin Wang, Jianse Zhang, Yuqiang Ding and 2 more

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. [Decellularized matrix of human fatty liver used for three-dimensional culture of hepatocellular carcinoma cells].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jin MeiAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Yaling YuAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Miaozhong LiMedical School of Ningbo University, Ningbo, 315211, China.
Shanshan XiAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Sixiao ZhangMedical School of Ningbo University, Ningbo, 315211, China.
Xiaolin LiuAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Junqun JiangAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Zhibin WangInstitute of Bioscaffold Transplantation and Immunology, Wenzhou Medical University, Wenzhou, 325035, China.
Jianse ZhangAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.
Yuqiang DingInstitute of Neuroscience, Wenzhou Medical University, Wenzhou, 325035, China.
Xinfa LouInstitute of Bioscaffold Transplantation and Immunology, Wenzhou Medical University, Wenzhou, 325035, China.
Maolin TangAnatomy Department, Wenzhou Medical University, Wenzhou, 325035, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are increasing numbers of patients underwent partial nephrectomy, and recovery of disturbed renal function is imperative post partial nephrectomy. We previously have demonstrated the decellularized (DC) scaffolds could mediate the residual kidney regeneration and thus improve disturbed renal function after partial nephrectomy. However, the cellular changes including the angiogenesis in the implanted DC scaffold has not yet been elaborated. In this study, we observed that the scaffold promoted the proliferation of human umbilical vein endothelial cells (HUVEC) that adhered to the DC scaffold in vitro. We next examined the pathological changes of the implanted DC graft in vivo, and found a decreased volume of the scaffold and a dramatic angiogenesis within the scaffold. The average microvessel density (aMVD) increased at the early stage, while decreased at the later stage post transplantation. Expression level of vascular endothelial growth factor (VEGF) showed similar dynamic changes. In addition, many endothelial cells (ECs) and endothelial progenitor cells (EPCs) were distributed in the region which contained active angiogenesis in the scaffold. However, the implanted graft became fibrosis and the angiogenesis degraded at final stage roughly 8 weeks post transplantation. Our data indicate that DC scaffold can be vascularized in vivo and possible mechanisms are discussed.

Indexed as

RegenerationTissue ScaffoldsAC133 AntigenAnimalsBlood VesselsCells, CulturedCell TransplantationHumansHuman Umbilical Vein Endothelial CellsKidneyNeovascularization, PhysiologicNephrectomyRats, Sprague-DawleyTissue EngineeringTransplantation, HeterologousVascular Endothelial Growth Factor AAC133 AntigenVascular Endothelial Growth Factor Aangiogenesisdecellularized scaffoldsendothelial cellsendothelial progenitor cellskidney regeneration

Identifiers

PMID27058889
PMCPMC5053634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.